QLGN logo

QLGN
Qualigen Therapeutics Inc

37,137
Mkt Cap
$9.68M
Volume
0.00
52W High
$8.81
52W Low
$1.61
PE Ratio
-0.42
QLGN Fundamentals
Price
$4.71
Prev Close
$3.53
Open
$5.79
50D MA
$3.24
Beta
0.49
Avg. Volume
4.52M
EPS (Annual)
-$17.28
P/B
-1.34
Loading...
Loading...
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Qualigen Therapeutics Inc?
What is the 52-week high for Qualigen Therapeutics Inc?
What is the 52-week low for Qualigen Therapeutics Inc?
What is the PE ratio of Qualigen Therapeutics Inc?
What is the Price-to-Book ratio of Qualigen Therapeutics Inc?
What is the 50-day moving average of Qualigen Therapeutics Inc?

Latest QLGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.